Recent advances in anticoagulant drug delivery

Expert Opin Drug Deliv. 2016;13(3):421-34. doi: 10.1517/17425247.2016.1125880. Epub 2015 Dec 23.

Abstract

Introduction: Anticoagulants have been prescribed to patients to prevent deep vein thrombosis or pulmonary embolism. However, because of several problems in anticoagulant therapy, much attention has been directed at developing an ideal anticoagulant, and numerous attempts have been made to develop new anticoagulant delivery systems in recent years.

Areas covered: This review discusses the challenges associated with the recent development of anticoagulants and their delivery systems. Various delivery methods have been developed to improve the use of anticoagulants. Recent advances in anticoagulant delivery and antidote development are also discussed in the context of their current progression states.

Expert opinion: There have been many different approaches to developing the delivery system of anticoagulants. One approach has been to expand the use of new oral agents and develop their antidotes. Reducing the size of heparins to use smaller heparins for delivery, and developing oral or topical heparins are also some of the approaches used. Various physical formulations or chemical modifications are other ways that have enhanced the therapeutic potential of anticoagulant agents. On the whole, recent advances have contributed to increasing the efficacy and safety of anticoagulant clinically and have benefited the field of anticoagulant delivery.

Keywords: Anticoagulant; NOACs; drug delivery; heparin; oral delivery; thrombosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anticoagulants / administration & dosage*
  • Drug Delivery Systems*
  • Heparin / administration & dosage*
  • Humans

Substances

  • Anticoagulants
  • Heparin